|
Post by JHam on Feb 10, 2021 2:21:27 GMT
KMPH paid down the last outstanding portion of it's debt with Deerfield. Great news. Seems like lots of people don't quite understand today's filings and panic sold AH. Registered 7.94M warrants issued the other day (old news): www.sec.gov/Archives/edgar/data/1434647/000143774921002346/kmph20210203_s3.htmDebt paid off to Deerfield, termination of facility agreement (new) www.sec.gov/Archives/edgar/data/1434647/000143774921002351/kmph20210209_8k.htmAnd here are the investors in the recent public offering. Sabby is there which has made some nervous given their history of shorting. It makes no sense that they'd short this at this time, imo. Also, this confirms my back-of-the-napkin math that the new o/s amount is 18.85M: SELLING STOCKHOLDERS
We are registering the resale of 7,944,430 shares of common stock issuable upon exercise of the Warrants held by the selling stockholders identified below, to permit each of them, or their respective transferees, pledgees, distributees and other successors-in-interest that may be identified in a supplement to this prospectus or, if required, a post-effective amendment to the registration statement of which this prospectus is a part, to resell or otherwise dispose of such shares of common stock in the manner contemplated under the section entitled “Plan of Distribution” in this prospectus (as may be supplemented and amended).
The selling stockholders may sell some, all or none of their shares in this offering, and these shares of common stock may be offered only after exercise of all or a portion of the Warrants held by a selling stockholder. We cannot predict when or if the selling stockholders will exercise their Warrants, and following any such exercise, we do not know how long the selling stockholders will hold the shares before selling them. We currently have no agreements, arrangements or understandings with the selling stockholders regarding the sale or other disposition of any of the shares. The shares covered hereby may be offered from time to time by the selling stockholders. As a result, we cannot estimate the number of shares of common stock each of the selling stockholders will beneficially own after termination of sales under this prospectus. In addition, each of the selling stockholders may have sold, transferred or otherwise disposed of all or a portion of its shares of common stock since the date on which it provided information for this table.
Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to our common stock. Generally, a person “beneficially owns” shares of our common stock as of a date if the person has or shares with others the right to vote those shares or to dispose of them on that date, or if the person has the right to acquire voting or disposition rights within 60 days of that date.
The information in the table below and the footnotes thereto regarding shares of common stock to be beneficially owned after the offering assumes the sale of all shares being offered by the selling stockholders under this prospectus. The percentage of shares owned prior to and after the offering is based on 18,849,983 shares of common stock outstanding as of January 31, 2021. Unless otherwise indicated, the address for the persons and entities listed in the table below is c/o KemPharm, Inc., 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747.
|
|
|
Post by JHam on Feb 10, 2021 14:55:23 GMT
$10
|
|
|
Post by magnus123 on Feb 10, 2021 16:04:20 GMT
$10 Holy volatility. The market maybe appreciates that they finally cleared the debt with Deerfield. I will take a look into the last 10Q to understand the terms of the agreement. The great thing is that we are still early here. A lot of days to run
|
|
|
Post by JHam on Feb 10, 2021 16:21:22 GMT
$10 Holy volatility. The market maybe appreciates that they finally cleared the debt with Deerfield. I will take a look into the last Q4 to understand the terms of the agreement. The great thing is that we are still early here. A lot of days to run You know you’ve entered cult-stock status when people at ST are predicting imminent $3B buyouts or $102 pps valuations right after FDA approval. Don’t get me wrong, I’d take either, but I don’t think we’ll get there...just yet lol. Although you never know. With the massive pumping going on anything is possible. Up past 12K followers now on ST.
|
|
|
Post by magnus123 on Feb 10, 2021 16:27:47 GMT
Holy volatility. The market maybe appreciates that they finally cleared the debt with Deerfield. I will take a look into the last Q4 to understand the terms of the agreement. The great thing is that we are still early here. A lot of days to run You know you’ve entered cult-stock status when people at ST are predicting imminent $3B buyouts or $102 pps valuations right after FDA approval. Don’t get me wrong, I’d take either, but I don’t think we’ll get there...just yet lol. Although you never know. With the massive pumping going on anything is possible. Up past 12K followers now on ST. The great thing, when you have a cultstock is that fundamentals doesn't matter anymore. The best example is CTRM. The fair value is maybe $0.20, but it's trading above $1 with an insane valuation. With KMPH, anything is possible now and we will maybe not see a "sell the news" event, if they achieve approval. Because of the cult status. But i don't believe in $100 after approval. But it would be funny it it hits 100, while we sold for $15
|
|
|
Post by JHam on Feb 10, 2021 16:55:21 GMT
You know you’ve entered cult-stock status when people at ST are predicting imminent $3B buyouts or $102 pps valuations right after FDA approval. Don’t get me wrong, I’d take either, but I don’t think we’ll get there...just yet lol. Although you never know. With the massive pumping going on anything is possible. Up past 12K followers now on ST. The great thing, when you have a cultstock is that fundamentals doesn't matter anymore. The best example is CTRM. The fair value is maybe $0.20, but it's trading above $1 with an insane valuation. With KMPH, anything is possible now and we will maybe not see a "sell the news" event, if they achieve approval. Because of the cult status. But i don't believe in $100 after approval. But it would be funny it it hits 100, while we sold for $15 LOLOLOL! You know us too well Depending on where we are in 2 weeks, I may just hang on through the PDUFA date and set a stop-loss order to be safe. Corium is going to buy out KMPH if they win approval, I think it’s pretty obvious. It’s just a matter of time.
|
|
|
Post by JHam on Feb 11, 2021 7:14:34 GMT
There was a new patent approved on Monday. Elsewhere many are trying to make a bigger deal of it than it is. Apparently this patent should take us to $15 tomorrow, lol. Based on the crazy pumping going on about it I won't count it out. Patent approval is a good thing no doubt, but if they acted as major catalysts for the pps I would have been rich long ago with ACTC uspto.report/patent/grant/10,912,744
|
|
|
Post by magnus123 on Feb 11, 2021 9:18:50 GMT
There was a new patent approved on Monday. Elsewhere many are trying to make a bigger deal of it than it is. Apparently this patent should take us to $15 tomorrow, lol. Based on the crazy pumping going on about it I won't count it out. Patent approval is a good thing no doubt, but if they acted as major catalysts for the pps I would have been rich long ago with ACTC uspto.report/patent/grant/10,912,744 New patents are always nice
|
|
|
Post by magnus123 on Feb 12, 2021 14:55:56 GMT
Added more at $9.15, but only a few shares to keep my avg low.
|
|
|
Post by JHam on Feb 13, 2021 16:05:30 GMT
|
|
|
Post by wanderer on Feb 13, 2021 16:26:45 GMT
Caeser! And boy do I miss A Blind Rat. I wish I had listened to his warnings just a little more. I do want to thank all of you for your insights and DD. My Portfolio thanks you too!
|
|
|
Post by JHam on Feb 13, 2021 16:59:08 GMT
Caeser! And boy do I miss A Blind Rat. I wish I had listened to his warnings just a little more. I do want to thank all of you for your insights and DD. My Portfolio thanks you too! ABR, the legend. I miss that guy. Super smart and fascinating person. I had the honor of having a beer and curry in Brick Lane in London about 10 years ago. 10 years!! Sheesh, time flies... Glad to hear that your portfolio is doing well!
|
|
|
Post by vzveteran on Feb 13, 2021 17:47:05 GMT
Wow, Blast from the past! I know all about this Lol. You can go further than the BOD AND the other shareholders, should this happen and they accept any offer. You can perfect your rights as an individual shareholder,and negotiate your own deal. You must do this within a set timeframe post any accepted offer. I added more yesterday as well.😎
|
|
|
Post by JHam on Feb 13, 2021 17:56:09 GMT
Wow, Blast from the past! I know all about this Lol. You can go further than the BOD AND the other shareholders, should this happen and they accept any offer. You can perfect your rights as an individual shareholder,and negotiate your own deal. You must do this within a set timeframe post any accepted offer. I added more yesterday as well.😎 Yeah, didn’t you win arbitration? You know I just went back and forth with this poster at ST. He kind of does remind me of Ceasar...🤔😂
|
|
|
Post by vzveteran on Feb 13, 2021 18:04:37 GMT
Wow, Blast from the past! I know all about this Lol. You can go further than the BOD AND the other shareholders, should this happen and they accept any offer. You can perfect your rights as an individual shareholder,and negotiate your own deal. You must do this within a set timeframe post any accepted offer. I added more yesterday as well.😎 Yeah, didn’t you win arbitration? You know I just went back and forth with this poster at ST. He kind of does remind me of Yep, We reached a deal.but It took about year and a half. I'd do it again for sure.
|
|
|
Post by JHam on Feb 13, 2021 18:17:43 GMT
Yeah, didn’t you win arbitration? You know I just went back and forth with this poster at ST. He kind of does remind me of Yep, We reached a deal.but It took about year and a half. I'd do it again for sure. Amazing!
|
|
|
Post by JHam on Feb 14, 2021 3:55:53 GMT
Caeser! And boy do I miss A Blind Rat. I wish I had listened to his warnings just a little more. I do want to thank all of you for your insights and DD. My Portfolio thanks you too! Holy hell. Could this be Ceasar? LOL! doctor01Biotech, Refresh my memory. Didn't Astellas come in to ACTC as a "partner"...exactly the same way that Corium has come in as a "partner" to KemPharm. AND AT THE LAST MINUTE, DECIDED TO TAKE THE WHOLE ENCHILADA AT A STEAL?doctor01The exact numbers would give you right at $37 per share. Most people would jump at that! I WOULD NOT!doctor01YOU WANT TO USE A MULTIPLE ON A COMPANY WHO HAS PREVIOUSLY BEEN DESTROYED BY THE PERFECT STORM? YOU WANT TO USE A MULTIPLE BASED ON THAT TOTALLY STUPID LOW VALUE? YOU WANT TO USE A MULTIPLE ON A COMPANY THAT IS NOW DEBT FREE, HAS A PLATFORM THAT IS EXTRODINARY? YOU WANT TO USE A MULTIPLE ON A COMPANY THAT HAS SACRIFIED TO GET TO THE NASDAQ, SO THE BIG BOYS CAN PLAY? Just ask'in..... (I honestly don't believe that you agree with everything that I say "EXCEPT" the multiple. I could be misinterpreting you and would like to continue the discussion, but I have my doubts.)Or is this Ceasar? @waynd01I was in ACTC and I remember everything. BiotechInvestor is comparing apples and oranges here. ACTC's situation was very different. ACTC was working on an unproven and controversial tech ( stem cell from Embryo) . The tech was promising and disruptive but it was light years from productive. The buy out was in phase 1. If there was no buy out they would have spent millions and millions of dollars. How that money would have come to ACTC if no buy out was there? Why there was no much interest from other parties other than Astella? Their buy out was in 2015 I think. I do not their product is in market yet even after the 6 years!1 $KMPH situation is very different. The tech is not a rocket science. The underlying drug is already approved. The prodrug tech is already validated. We have completed phase 3 and just 2 weeks away from approval. We have got the top notch marketing partner..$KMPHis actually in the driving seat now..I'm sure they are not him, but it's interesting how they are so familiar with ACTC, know the story, and are trying to create the same cult-like atmosphere around KMPH.
|
|
|
Post by JHam on Feb 14, 2021 3:59:21 GMT
Caeser! And boy do I miss A Blind Rat. I wish I had listened to his warnings just a little more. I do want to thank all of you for your insights and DD. My Portfolio thanks you too! Holy hell. Could this be Ceasar? LOL! doctor01 Biotech, Refresh my memory. Didn't Astellas come in to ACTC as a "partner"...exactly the same way that Corium has come in as a "partner" to KemPharm. AND AT THE LAST MINUTE, DECIDED TO TAKE THE WHOLE ENCHILADA AT A STEAL?doctor01 The exact numbers would give you right at $37 per share. Most people would jump at that! I WOULD NOT!doctor01 YOU WANT TO USE A MULTIPLE ON A COMPANY WHO HAS PREVIOUSLY BEEN DESTROYED BY THE PERFECT STORM? YOU WANT TO USE A MULTIPLE BASED ON THAT TOTALLY STUPID LOW VALUE? YOU WANT TO USE A MULTIPLE ON A COMPANY THAT IS NOW DEBT FREE, HAS A PLATFORM THAT IS EXTRODINARY? YOU WANT TO USE A MULTIPLE ON A COMPANY THAT HAS SACRIFIED TO GET TO THE NASDAQ, SO THE BIG BOYS CAN PLAY? Just ask'in..... (I honestly don't believe that you agree with everything that I say "EXCEPT" the multiple. I could be misinterpreting you and would like to continue the discussion, but I have my doubts.)Or is this Ceasar? @waynd01 I was in ACTC and I remember everything. BiotechInvestor is comparing apples and oranges here. ACTC's situation was very different. ACTC was working on an unproven and controversial tech ( stem cell from Embryo) . The tech was promising and disruptive but it was light years from productive. The buy out was in phase 1. If there was no buy out they would have spent millions and millions of dollars. How that money would have come to ACTC if no buy out was there? Why there was no much interest from other parties other than Astella? Their buy out was in 2015 I think. I do not their product is in market yet even after the 6 years!1 $KMPH situation is very different. The tech is not a rocket science. The underlying drug is already approved. The prodrug tech is already validated. We have completed phase 3 and just 2 weeks away from approval. We have got the top notch marketing partner..$KMPHis actually in the driving seat now..I'm sure they are not him, but it's interesting how they are so familiar with ACTC, know the story, and are trying to create the same cult-like atmosphere around KMPH. For the record, the bolded post above was a response to this post from me: Right. Corium will have to justify to Bertarelli why they want him to pay a massive premium for a company that may not even have a $500M market valuation. I remember when retail shareholders tried to do something similar with ACTC many years ago. Of course it went nowhere and instead of shareholders selling at peak value, most held out for the multi-billion dollar buyout that never happened. Eventually Astellas bought them for $379M, and the shareholders who held the stock for years and years were left beside themselves. I got out before the buyout, thank god. It was brutal emotionally for those who held on: www.bizjournals.com/boston/blog/bioflash/2015/11/ocatas-379m-acquisition-leaves-many-small.html
I responded to the bolded post with the following: The ACTC comparison is not about the type of science or the stage of development. In that way ACTC and KMPH are very different. It’s about the size of the retail shareholder base and the attempt to mobilize everyone to reject any upcoming tender offer and NOT SELL YOUR SHARES!! Lol. In that way they are almost identical.
|
|
|
Post by JHam on Feb 15, 2021 2:17:03 GMT
I'm surprised how many followers this ticker has on ST. I also like how actively traded this stock is. ST followers keeps on growing. Good chance this gets pumped like crazy the next few weeks, even more than it is now. Over 13,000 followers now. I think it was in the 10s when we first started discussing this stock a couple weeks ago.
|
|
|
Post by lcd on Feb 15, 2021 3:39:48 GMT
That buyout doc sure screams out Caesar de Cuenca. I forgot about that guy and his following. If I remember correctly, he claimed to be a medical doctor so someone named doctor01 definitely could be him.
I picked up a few shares of this on Friday and I will look to pick some more up on Tuesday, but I am a little cautious because this isn't a new drug so it will require good marketing to get penetration into that existing market.
|
|